US generic drug tariff to have limited near-term impact on Indian firms: Report
New Delhi, July 25 (IANS) The phased tariff plan announced by the US administration on imported generic medicines is expected to have a limited impact on the credit profiles of Indian pharmaceutical companies over the next two financial years, a report said on Saturday.